Regression of Yoshida sarcoma during normoxic and hypoxic conditions after fractionated radiotherapy;Regression des Yoshida-Sarkoms unter Normoxie und Hypoxie nach fraktionierter Bestrahlung

Strahlentherapie und Onkologie

Volumn 173, Issue 3, 1997, Pages 141-145

  Strnad, V ^a,c   Kamprad, F ^b   Jahns, J ^b   Meyer, M ^a   Bohme R ^b   Madaj Sterba, P ^b   Kirschner, M ^a   Sauer, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER REGRESSION; CONTROLLED STUDY; HYPOXIA; MALE; NONHUMAN; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION; RAT; YOSHIDA SARCOMA;

EID: 0030973653     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03039271     Document Type: Article

References (31)

1. Brenner, D. J.: Dose, volume, and tumor-control predictions in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26 (1993), 171-179.
2. Denekamp, J.: The relationship between the "cell loss factor" and the immediate response to radiation in animal tumours. Europ. J. Cancer 8 (1972), 335-440.
3. Denekamp, J.: Tumour regression as a guide to prognosis: a study with experimental animals. Brit. J. Radiol. 50 (1977), 271-279.
4. Dickson, J. A., S. K. Calderwood: Effects of hyperglycemia and hyperthermia on the pH, glycolysis, and respiration of the Yoshida sarcoma in vivo. J. nat. Cancer Inst. 63 (1979), 1371-1381.
5. Fochem, K., W. Michalica, E. Picha: Tageszeitlich differente Strahlenwirkung bei Ratten mit Yoshida-Sarkom. Strahlentherapie 132 (1967), 618-622.
6. Grau, C., M. R. Horsman, J. Overgaard: Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992), 421-424
7. Grossman, I., S. S. Kurohara, J. H. Webster, F. W. George: The prognostic significance of tumor response during radiotherapy in cervical carcinoma. Radiology 107 (1973), 411-415.
8. Jarmonenko, S. P.: Radiobiology of humans and animals. Mir Publishers, Moscow 1988, p. 348-355
9. Jarmonenko, S. P., K. Neumeister, A. A. Vainson, V. M. Krimker, N. L. Smakova, E. P. Petrosjan, W. Oelßner, H. Mehlhom, F. Koch, P. Arnold, U. Johannsen, J. Jahns, F. Kamprad: Experimentelle Grundlagen für den Einsatz der Hypoxie in der Strahlentherapie. Radiobiol. Radiother. 3 (1975), 319-329.
10. Karrer, K., O. Henn: Über den Einfluß von kleinen Dosen Radium-Emanation auf das Yoshida-Sarkom der Ratte. Strahlentherapie 138 (1969), 481-488.
11. Katz, E., M. Nyska, E. Okon, G. Zajicek, G. Robbin: Growth rate analysis of lung metastases from histologically benign giant cell tumor of bone. Cancer 59 (1987), 1831-1836.
12. Lee, I., J. H. Kim, S. H. Levitt, C. W. Song: Increases in tumor response by pentoxifylline alone or in combination with nicotamide. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992), 425-429.
13. Lee, I., S. H. Levitt, C. W. Song: Effect of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice. Radiat. Res. 112 (1987), 173-182.
14. Liszka, G., G. Németh, J. Hegeyesi: Die aktuelle Bewertung strahlentherapeutischer Behandlungsergebnisse. Strahlenther. Onkol. 170 (1994), 643-647.
15. Mäntylä, M., A. E. Kortekangas, R. A. Valavaara, E. M. Nordman: Tumour regression during radiation treatment as guide to prognosis. Brit. J. Radiol. 52 (1979), 972-977.
16. Marcial, V. A., A. Bosch: Radiation-induced tumour regression in carcinoma of the uterine cervix: prognostic significance. Amer. J. Roentgenol. 108 (1970), 113-123.
17. 252Cf neutron brachytherapy versus conventional photon brachytherapy. Amer. J. clin. Oncol. 7 (1984), 347-352.
18. Nguyen, T. V., K. Albert, A. Karai, I. Szarvassy, L. Takacs: Effect of Yoshida ascites tumour on the circulation in rats. Acta physiol. hung. 66 (1985), 155-159.
19. Rolle, D. J., K. H. Kretschmar: Zur Angiostruktur des intramuskulär implantierten Yoshida-Sarkoms bei unbehandelten und bei mit Lithiumkarmin behandelten Ratten. Zbl. allg. Path. 120 (1976), 383-390.
20. Savovski, K,. N. Pujic, V. Vranic, B. Dimitrijevic: Effects of a modified CMF treatment (cyclophosphamide, methotrexate and 5-fluorouracil) on hematopoetic tissues and Yoshida sarcoma in rats. Acta Oncol. 33 (1994), 793-798.
21. Schneider, R.: Vergleichende Untersuchungen über die Wirksamkeit einiger Zytostatika und der Strahlenbehandlung bei Impftumoren im Modellversuch unter besonderer Berücksichtigung der Telegammatherapie mit Kobalt 60. Überlebensversuche und Heilungen nach Zyklophosphamidester-, Trisathyleniminobenzochinon- und Strahlenbehandlung einzeln und in verschiedenen Kombinationen beim Yoshida-Sardom, Walker-Karzinosarkom und Jensen-Sarkom an Albinoratten. Strahlentherapie 61, Sonderbd. (1965), 367-672.
22. Schreibmayer, W., R. J. Schaur, H. M. Tillian, E. Schauenstein, K. Hagmuller: Tumor host relations. IV. Tissue distribution of citric acid cycle intermediates and of glutamate in tumor-bearing rats high level of alpha-ketoglutarate in solid Yoshida sarcomas. J. Cancer Res. clin. Oncol. 97 (1980), 137-144.
23. Sobel, S., P. Rubin, B. Keller, C. Poulter: Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 1 (1976), 873-880.
24. Steel G. G.: The growth rate of tumours. In: Steel, G. G. (ed.): Basic clinical radiobiology for radiation oncologist. Edward Arnold Publishers, London 1993, p. 8-13.
25. Steel, G. G.: The growth kinetics of tumours. Oxford University Press, Oxford 1977.
26. Strnad, V., F. Kamprad, J. Jahns, L. Keilholz, P. M. Sterba, R. Böhme, M. Kirschner, S. Birkenbake, R. Sauer: Hypoxie-Radiotherapie: Veränderungen in der Sauerstoffpartialdruckverteilung im Tumor und im gesunden Gewebe unter akuter respiratorischer Hypoxie. Strahlenther. Onkol. 172 (1996), 427-433.
27. Tacev, T., B. Prokes, V. Strnad, O. Rasovska, V. Krystof, D. Nikodemova: Effect of small doses of 252-Cf on the tumor regression in cervix uteri during combined radiotherapy. Strahlenther. Onkol. 165 (1989), 837-843.
28. Thomlinson, R. H., S. Dische, A. J. Gray, L. M. Errington: Clinical testing of the radiosensitizer Ro-07-0582. III. Response of tumours. Clin. Radiol. 27 (1976), 167-174.
29. Tsuchiya, H., Y. Tsuchiya, T. Kobayashi, Y. Kikuchi, O. Hino: Isolation of genes differentially expressed between the Yoshida sarcoma and long-survival Yoshida-sarcoma variants: origin of Yoshida sarcoma revisited. Jap. J. Cancer Res. 85 (1994), 1099-1104.
30. Vacek, A., D. Rotkovska, A. Bartonickova, T. Tacev: Differences in the radioprotective effects of hypoxic hypoxia in normal tissues and in experimental tumors. Int. J. Radiat. Biol. 49 (1986), 858.
31. Watras, J., M. Widel: Modification of cancer cells radiosensitivity. III. Influence of the crabtree effect on radiosensitivity of Yoshida sarcoma solid tumours. Radiobiol. Radiother. 16 (1975), 581-587.